8-KAccepted Nov 12, 4:10 PM ET
Eledon Pharmaceuticals, Inc.: reports quarter ended Sep 30, 2026
Accepted (ET)
4:10 PM
Nov 12, 2026
Filed
Nov 12, 2026
Documents
11
Size
452.1 KB
Summary
Eledon Pharmaceuticals, Inc.: reports quarter ended Sep 30, 2026
What happened Eledon Pharmaceuticals, Inc. announced on Nov 12, 2026 that it issued a press release regarding its quarter ended Sep 30, 2026. The 8-K states the information in the report, including the press release, is furnished to comply with the requirements of the Securities Exchange Act of 1934.
Key details
- Item reported: Item 2.02, results of operations and financial condition.
- Date of press release and filing: Nov 12, 2026.
- Quarter covered: quarter ended Sep 30, 2026.
- The report was signed on Nov 12, 2026 by David-Alexandre C. Gros, M.D., chief executive officer.
Why it may matter The filing reports Item 2.02, which covers results of operations and financial condition for the quarter ended Sep 30, 2026, and states the press release was furnished in connection with that item. This filing does not show why the insider traded or why the company acted.